Vimpat
- Product NDC
- 70166-617
- 11-digit product format
- 701660617
- Labeler code
- 70166
- Product ID
- 70166-617_8e5f8332-1558-5835-e053-2a95a90ae120
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lacosamide
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Lohxa
- Application
- NDA022255
- Marketing category
- NDA
- Marketing start
- 2010-04-20
- Marketing end
- 0000-00-00
- Substance
- LACOSAMIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70166-617-10 | Vimpat | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | | 1 |
| 70166-617-10 | Vimpat | 20 in 1 PACKAGE | SOLUTION | 20 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70166-617 | VIMPAT (LACOSAMIDE) SOLUTION [LOHXA] | 1 | Legacy NDC, 2 package rows | 20190724_42b3cf1d-7898-46d3-90d0-7705cc4d5f83.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70166-617-10 | 70166061710 | 20 CUP, UNIT-DOSE in 1 PACKAGE (70166-617-10) > 5 mL in 1 CUP, UNIT-DOSE | 2019-07-23 | 0000-00-00 | No | No | Current |